When the ZNF384-EP300 fusion protein is expressed, EP300 loses its activity, provoking KLF4 and TP53 dysregulation that, combined with JAK/STAT activation, causes the uncontrolled progression of overt BCP-ALL [66]. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.